PhoenixBio Co (TSE:6190) Days Sales Outstanding : 55.52 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is PhoenixBio Co Days Sales Outstanding?

PhoenixBio Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円272 Mil. PhoenixBio Co's Revenue for the three months ended in Dec. 2023 was 円447 Mil. Hence, PhoenixBio Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 55.52.

The historical rank and industry rank for PhoenixBio Co's Days Sales Outstanding or its related term are showing as below:

TSE:6190' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.85 Med: 52.75 Max: 67.4
Current: 59.86

During the past 9 years, PhoenixBio Co's highest Days Sales Outstanding was 67.40. The lowest was 21.85. And the median was 52.75.

TSE:6190's Days Sales Outstanding is ranked better than
59.75% of 892 companies
in the Biotechnology industry
Industry Median: 72.245 vs TSE:6190: 59.86

PhoenixBio Co's Days Sales Outstanding declined from Dec. 2022 (63.52) to Dec. 2023 (55.52).

PhoenixBio Co Days Sales Outstanding Historical Data

The historical data trend for PhoenixBio Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhoenixBio Co Days Sales Outstanding Chart

PhoenixBio Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

57.27

64.00

67.40

53.19

44.08

PhoenixBio Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															63.52	57.48	65.28	70.53	55.52

Competitive Comparison of PhoenixBio Co's Days Sales Outstanding

For the Biotechnology subindustry, PhoenixBio Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PhoenixBio Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's Days Sales Outstanding falls into.

PhoenixBio Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PhoenixBio Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (226.262	+	286.72)	/	2 )	/	2124.051	*	365
=	256.491					/	2124.051	*	365
=	44.08

PhoenixBio Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (342.566	+	201.235)	/	2 )	/	446.874	*	365 / 4
=	271.9005					/	446.874	*	365 / 4
=	55.52

PhoenixBio Co (TSE:6190) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PhoenixBio Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PhoenixBio Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PhoenixBio Co (TSE:6190) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhoenixBio Co Ltd (TSE:6190) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046

Website

http://www.phoenixbio.co.jp

PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.

PhoenixBio Co (TSE:6190) Headlines

No Headlines